Harini A Perera, N G Hasitha Raviranga, Olof Ramström, Mingdi Yan
{"title":"Trehalose-Functionalized Magnetic Affinity Probe Provides Biochemical Evidence of Nanoparticle Internalization in Mycobacteria.","authors":"Harini A Perera, N G Hasitha Raviranga, Olof Ramström, Mingdi Yan","doi":"10.1021/acsinfecdis.5c00506","DOIUrl":null,"url":null,"abstract":"<p><p>We developed a magnetic affinity probe (MAP), consisting of iron oxide magnetic nanoparticles (MNP) functionalized with a photoaffinity labeling agent perfluorophenyl azide (PFPA), to characterize the internalization of nanoparticles by <i>Mycobacterium smegmatis</i>. Two MAPs were synthesized: a trehalose-functionalized MAP, PFPA-MNP-Tre, and an ethanol-functionalized MAP, PFPA-MNP-OH. Following incubation of MAP with bacteria, the samples were irradiated to trigger covalent bond formation between PFPA and bacterial proteins. The captured proteins were isolated by cleaving the disulfide bond in the linkers and removing the magnetic nanoparticles by using a magnet. For PFPA-MNP-Tre incubated with <i>M. smegmatis</i> for 24 h, proteomic analysis revealed that the captured proteins are cytoplasmic mycobacterial proteins, which provided biochemical evidence for the internalization of nanoparticles in bacteria. Additionally, PFPA-MNP-Tre accumulated at the poles of the mycobacteria, and the amount of captured proteins decreased with increasing concentration of added free trehalose. These results underscore the role the surface ligand plays in modulating the uptake of nanoparticles. The modular MAP platform may find broad applications in studying mechanisms and processes involving nanoparticle-cell interactions.</p>","PeriodicalId":17,"journal":{"name":"ACS Infectious Diseases","volume":" ","pages":""},"PeriodicalIF":3.8000,"publicationDate":"2025-09-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Infectious Diseases","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1021/acsinfecdis.5c00506","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}
引用次数: 0
Abstract
We developed a magnetic affinity probe (MAP), consisting of iron oxide magnetic nanoparticles (MNP) functionalized with a photoaffinity labeling agent perfluorophenyl azide (PFPA), to characterize the internalization of nanoparticles by Mycobacterium smegmatis. Two MAPs were synthesized: a trehalose-functionalized MAP, PFPA-MNP-Tre, and an ethanol-functionalized MAP, PFPA-MNP-OH. Following incubation of MAP with bacteria, the samples were irradiated to trigger covalent bond formation between PFPA and bacterial proteins. The captured proteins were isolated by cleaving the disulfide bond in the linkers and removing the magnetic nanoparticles by using a magnet. For PFPA-MNP-Tre incubated with M. smegmatis for 24 h, proteomic analysis revealed that the captured proteins are cytoplasmic mycobacterial proteins, which provided biochemical evidence for the internalization of nanoparticles in bacteria. Additionally, PFPA-MNP-Tre accumulated at the poles of the mycobacteria, and the amount of captured proteins decreased with increasing concentration of added free trehalose. These results underscore the role the surface ligand plays in modulating the uptake of nanoparticles. The modular MAP platform may find broad applications in studying mechanisms and processes involving nanoparticle-cell interactions.
期刊介绍:
ACS Infectious Diseases will be the first journal to highlight chemistry and its role in this multidisciplinary and collaborative research area. The journal will cover a diverse array of topics including, but not limited to:
* Discovery and development of new antimicrobial agents — identified through target- or phenotypic-based approaches as well as compounds that induce synergy with antimicrobials.
* Characterization and validation of drug target or pathways — use of single target and genome-wide knockdown and knockouts, biochemical studies, structural biology, new technologies to facilitate characterization and prioritization of potential drug targets.
* Mechanism of drug resistance — fundamental research that advances our understanding of resistance; strategies to prevent resistance.
* Mechanisms of action — use of genetic, metabolomic, and activity- and affinity-based protein profiling to elucidate the mechanism of action of clinical and experimental antimicrobial agents.
* Host-pathogen interactions — tools for studying host-pathogen interactions, cellular biochemistry of hosts and pathogens, and molecular interactions of pathogens with host microbiota.
* Small molecule vaccine adjuvants for infectious disease.
* Viral and bacterial biochemistry and molecular biology.